XSTOHEGR
Market cap3mUSD
Dec 23, Last price
2.84SEK
1D
-2.07%
1Q
-23.24%
Jan 2017
-84.00%
IPO
-77.67%
Name
Hedera Group AB (publ)
Chart & Performance
Profile
Hedera Group AB (publ), together with its subsidiaries, engages in the staffing and recruitment of doctors and nurses to primary cares, municipalities, and hospitals in Sweden. It offers consulting services. The company is based in Stockholm, Sweden. Hedera Group AB (publ) is a subsidiary of Bertil Haglund med bolag.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 678,277 49.43% | 453,914 83.80% | 246,965 13.29% | |||||||
Cost of revenue | 644,040 | 344,922 | 194,607 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 34,237 | 108,992 | 52,358 | |||||||
NOPBT Margin | 5.05% | 24.01% | 21.20% | |||||||
Operating Taxes | 3,058 | (669) | 392 | |||||||
Tax Rate | 8.93% | 0.75% | ||||||||
NOPAT | 31,179 | 109,661 | 51,966 | |||||||
Net income | 9,461 -30.31% | 13,575 422.72% | 2,597 -232.36% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 22,051 | 4,320 | ||||||||
BB yield | -19.77% | -5.53% | ||||||||
Debt | ||||||||||
Debt current | 34,396 | 19,472 | 5,735 | |||||||
Long-term debt | 17,150 | 21,647 | 36,983 | |||||||
Deferred revenue | 2 | 575 | ||||||||
Other long-term liabilities | 381 | 380 | (1,000) | |||||||
Net debt | 36,485 | 32,305 | 36,779 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 12,796 | 10,091 | 1,777 | |||||||
CAPEX | (628) | (1,951) | (3,332) | |||||||
Cash from investing activities | (2,645) | (22,199) | (10,508) | |||||||
Cash from financing activities | (3,743) | 14,972 | 10,170 | |||||||
FCF | 15,109 | 117,986 | 48,878 | |||||||
Balance | ||||||||||
Cash | 15,061 | 8,653 | 5,789 | |||||||
Long term investments | 161 | 150 | ||||||||
Excess cash | ||||||||||
Stockholders' equity | 57,109 | 47,648 | 23,802 | |||||||
Invested Capital | 148,592 | 124,545 | 95,383 | |||||||
ROIC | 22.83% | 99.72% | 58.32% | |||||||
ROCE | 22.86% | 86.76% | 54.40% | |||||||
EV | ||||||||||
Common stock shares outstanding | 14,901 | 13,123 | 9,641 | |||||||
Price | 7.74 -8.94% | 8.50 4.94% | 8.10 78.41% | |||||||
Market cap | 115,333 3.40% | 111,545 42.83% | 78,094 93.20% | |||||||
EV | 151,818 | 143,850 | 114,873 | |||||||
EBITDA | 39,380 | 112,828 | 54,766 | |||||||
EV/EBITDA | 3.86 | 1.27 | 2.10 | |||||||
Interest | 3,571 | 2,592 | 1,654 | |||||||
Interest/NOPBT | 10.43% | 2.38% | 3.16% |